Form 4: Twist Bioscience Executive Sells Shares for Tax Withholding

Paula Green, SVP of Human Resources at Twist Bioscience Corp, reported a transaction involving the sale of 884 shares to cover tax withholding obligations upon the vesting of Restricted Stock Units.

Summary

• Paula Green, Senior Vice President of Human Resources at Twist Bioscience Corporation, has reported a transaction on June 8, 2026.
• The transaction involved the sale of 884 shares of common stock.
• These shares were sold to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• This sale was mandated by the company's equity incentive plans, which require a 'sell to cover' transaction to satisfy tax liabilities.
• Following this transaction, Paula Green beneficially owns 120,705 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a routine administrative event for tax purposes and does not reflect a change in the executive's investment strategy or the company's performance.

Positives

• The transaction is a standard 'sell to cover' to satisfy tax obligations, indicating no discretionary sale of shares by management.
• Paula Green continues to hold a significant number of shares (120,705) after the transaction, suggesting continued confidence in the company.

Negatives

• A portion of the executive's equity award was sold, which could be perceived negatively by some investors, although it's for tax purposes.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Management Comments

• "Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."
• "These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person."

Industry Context

StockSavvy.ai notes that Form 4 filings detailing 'sell to cover' transactions for tax withholding are common for executives in the biotechnology and life sciences sectors, especially following significant vesting events of equity compensation.

Stakeholder Impact

• Shareholders: The sale is for tax withholding and not a discretionary sale, so it is unlikely to have a significant negative impact on share price. The executive retains a substantial number of shares.

Key Dates

Keywords

Form 4, SEC Filing, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation, Twist Bioscience, Paula Green, Beneficial Ownership